Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer

Table 1

Local recurrence risk and tumor dose.

Tumor dose (Gray)	Local recurrence risk
	Arriagada et al. [5]	Van Limbergen et al. [6]
	% (number of patients)	% (number of patients)
≤50	77% (99/128)	75% (3/4)
51–60	68.7% (55/81)	21% (4/19)
61–70	54.8% (17/31)	16.6% (2/12)
71–80	31.7% (33/104)	24.4% (12/49)
>80	24% (13/54)	12.5% (17/136)